MERIDIAN BIOSCIENCE INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021	FY2020 12 months to Sep 30, 2020	FY2019 12 months to Sep 30, 2019	FY2018 12 months to Sep 30, 2018
Net Revenues
Cost of Sales
Gross Profit
Operating Expenses:
Research and development
Selling and marketing
General and administrative
Product recall costs (adjustment)
Acquisition and transaction related costs
Litigation and select legal costs
Restructuring costs
Change in fair value of acquisition consideration and settlement
Total Operating Expenses
Operating Income
Other Income (Expense):
Interest income
Interest expense
RADx grant income
Other, net
Total Other Expense, Net
Earnings Before Income Taxes
Income Tax Provision
Net Earnings
Earnings Per Share Data:
Basic earnings per common share
Diluted earnings per common share
Common shares used for basic earnings per common share
Effect of dilutive stock options and restricted share units
Common shares used for diluted earnings per common share
Dividends declared per common share
Anti-Dilutive Securities:
Common share options and restricted share units

Comments